Insulin Biosimilars - Global Market Outlook (2017-2023)

Insulin Biosimilars - Global Market Outlook (2017-2023)

  • Published: November 2017
  • ID: SMRC16818

According to Stratistics MRC, the Global Insulin Biosimilars market is estimated at $XX million in 2016 and is expected to reach $XX million by 2023 growing at a CAGR of XX% from 2016 to 2023. Growing pervasiveness of type 1 diabetes and ongoing approvals by the government authorities are nurturing the market growth. Some of the factors such as growing population exposures, technological developments and favorable medical repayment scenario in developed countries are poised to favour the market growth. However, patent protection rights of insulin and strong vengeance from the key manufacturers are some of the restraints limiting the market.

Expansion of clinically verified insulin biosimilar will cover the road for new entrants. The approaching patent expiration of insulin drugs will unlock new opportunities for the development of biosimilars and manufacturing companies. As cost is high due to strict observance requirements, prices of biosimilar drugs are anticipated to decrease as compared to branded drugs.

North America led the insulin biosimilars market due to rising demand for insulin in the region. Europe is anticipated to account for second largest share and Asia Pacific is expected to grow at a fastest rate during the forecast period. APAC players are competing on the basis of price and have pool of patients affected by diabetes, thus fueling the market growth.

Some of the key players in this market are Wockhardt Limited, Ypsomed AG, Pfizer Inc., Mylan N.V., Boehringer Ingelheim GmbH, NOVO Nordisk A/S, Sanofi S.A., Merck & Co., Biocon Limited and Eli Lilly & Co.

Biosimilars Types Covered:
• Rapid-Acting Biosimilars
• Long-Acting Biosimilars
• Premixed Biosimilars

Disease Indications Covered:
• Type I Diabetes
• Type II Diabetes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary       
         
2 Preface 
       
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 Emerging Markets      
 3.7 Futuristic Market Scenario     
         
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
         
5 Global Insulin Biosimilars Market, By Biosimilars Type    
 5.1 Introduction       
 5.2 Rapid-Acting Biosimilars     
 5.3 Long-Acting Biosimilars     
 5.4 Premixed Biosimilars     
         
6 Global Insulin Biosimilars Market, By Disease Indication   
 6.1 Introduction       
 6.2 Type I Diabetes      
 6.3 Type II Diabetes      
         
7 Global Insulin Biosimilars Market, By Geography    
 7.1 Introduction       
 7.2 North America      
  7.2.1 US      
  7.2.2 Canada      
  7.2.3 Mexico      
 7.3 Europe       
  7.3.1 Germany       
  7.3.2 U.K.      
  7.3.3 Italy      
  7.3.4 France      
  7.3.5 Spain       
  7.3.6 Rest of Europe     
 7.4 Asia Pacific      
  7.4.1 Japan      
  7.4.2 China      
  7.4.3 India      
  7.4.4 Australia      
  7.4.5 New Zealand     
  7.4.6 South Korea     
  7.4.7 Rest of Asia Pacific     
 7.5 South America      
  7.5.1 Argentina     
  7.5.2 Brazil      
  7.5.3 Chile      
  7.5.4 Rest of South America    
 7.6 Middle East & Africa     
  7.6.1 Saudi Arabia     
  7.6.2 UAE      
  7.6.3 Qatar      
  7.6.4 South Africa     
  7.6.5 Rest of Middle East & Africa    
         
8 Key Developments       
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 8.2 Acquisitions & Mergers     
 8.3 New Product Launch     
 8.4 Expansions      
 8.5 Other Key Strategies     
         
9 Company Profiling       
 9.1 Wockhardt Limited      
 9.2 Ypsomed AG      
 9.3 Pfizer Inc.      
 9.4 Mylan N.V.      
 9.5 Boehringer Ingelheim GmbH     
 9.6 NOVO Nordisk A/S      
 9.7 Sanofi S.A.       
 9.8 Merck & Co.      
 9.9 Biocon Limited      
 9.10 Eli Lilly & Co.   


List Of Tables        
1 Global Insulin Biosimilars Market Outlook, By Region (2014-2023) ($MN)  
2 Global Insulin Biosimilars Market Outlook, By Biosimilars Type (2014-2023) ($MN) 
3 Global Insulin Biosimilars Market Outlook, By Rapid-Acting Biosimilars (2014-2023) ($MN)
4 Global Insulin Biosimilars Market Outlook, By Long-Acting Biosimilars (2014-2023) ($MN)
5 Global Insulin Biosimilars Market Outlook, By Premixed Biosimilars (2014-2023) ($MN)
6 Global Insulin Biosimilars Market Outlook, By Disease Indication (2014-2023) ($MN)
7 Global Insulin Biosimilars Market Outlook, By Type I Diabetes (2014-2023) ($MN) 
8 Global Insulin Biosimilars Market Outlook, By Type II Diabetes (2014-2023) ($MN) 
9 North America Insulin Biosimilars Market Outlook, By Country (2014-2023) ($MN) 
10 North America Insulin Biosimilars Market Outlook, By Biosimilars Type (2014-2023) ($MN)
11 North America Insulin Biosimilars Market Outlook, By Rapid-Acting Biosimilars (2014-2023) ($MN)
12 North America Insulin Biosimilars Market Outlook, By Long-Acting Biosimilars (2014-2023) ($MN)
13 North America Insulin Biosimilars Market Outlook, By Premixed Biosimilars (2014-2023) ($MN)
14 North America Insulin Biosimilars Market Outlook, By Disease Indication (2014-2023) ($MN)
15 North America Insulin Biosimilars Market Outlook, By Type I Diabetes (2014-2023) ($MN)
16 North America Insulin Biosimilars Market Outlook, By Type II Diabetes (2014-2023) ($MN)
17 Europe Insulin Biosimilars Market Outlook, By Country (2014-2023) ($MN) 
18 Europe Insulin Biosimilars Market Outlook, By Biosimilars Type (2014-2023) ($MN) 
19 Europe Insulin Biosimilars Market Outlook, By Rapid-Acting Biosimilars (2014-2023) ($MN)
20 Europe Insulin Biosimilars Market Outlook, By Long-Acting Biosimilars (2014-2023) ($MN)
21 Europe Insulin Biosimilars Market Outlook, By Premixed Biosimilars (2014-2023) ($MN)
22 Europe Insulin Biosimilars Market Outlook, By Disease Indication (2014-2023) ($MN)
23 Europe Insulin Biosimilars Market Outlook, By Type I Diabetes (2014-2023) ($MN) 
24 Europe Insulin Biosimilars Market Outlook, By Type II Diabetes (2014-2023) ($MN) 
25 Asia Pacific Insulin Biosimilars Market Outlook, By Country (2014-2023) ($MN) 
26 Asia Pacific Insulin Biosimilars Market Outlook, By Biosimilars Type (2014-2023) ($MN)
27 Asia Pacific Insulin Biosimilars Market Outlook, By Rapid-Acting Biosimilars (2014-2023) ($MN)
28 Asia Pacific Insulin Biosimilars Market Outlook, By Long-Acting Biosimilars (2014-2023) ($MN)
29 Asia Pacific Insulin Biosimilars Market Outlook, By Premixed Biosimilars (2014-2023) ($MN)
30 Asia Pacific Insulin Biosimilars Market Outlook, By Disease Indication (2014-2023) ($MN)
31 Asia Pacific Insulin Biosimilars Market Outlook, By Type I Diabetes (2014-2023) ($MN)
32 Asia Pacific Insulin Biosimilars Market Outlook, By Type II Diabetes (2014-2023) ($MN)
33 South America Insulin Biosimilars Market Outlook, By Country (2014-2023) ($MN) 
34 South America Insulin Biosimilars Market Outlook, By Biosimilars Type (2014-2023) ($MN)
35 South America Insulin Biosimilars Market Outlook, By Rapid-Acting Biosimilars (2014-2023) ($MN)
36 South America Insulin Biosimilars Market Outlook, By Long-Acting Biosimilars (2014-2023) ($MN)
37 South America Insulin Biosimilars Market Outlook, By Premixed Biosimilars (2014-2023) ($MN)
38 South America Insulin Biosimilars Market Outlook, By Disease Indication (2014-2023) ($MN)
39 South America Insulin Biosimilars Market Outlook, By Type I Diabetes (2014-2023) ($MN)
40 South America Insulin Biosimilars Market Outlook, By Type II Diabetes (2014-2023) ($MN)
41 Middle East & Africa Insulin Biosimilars Market Outlook, By Country (2014-2023) ($MN)
42 Middle East & Africa Insulin Biosimilars Market Outlook, By Biosimilars Type (2014-2023) ($MN)
43 Middle East & Africa Insulin Biosimilars Market Outlook, By Rapid-Acting Biosimilars (2014-2023) ($MN)
44 Middle East & Africa Insulin Biosimilars Market Outlook, By Long-Acting Biosimilars (2014-2023) ($MN)
45 Middle East & Africa Insulin Biosimilars Market Outlook, By Premixed Biosimilars (2014-2023) ($MN)
46 Middle East & Africa Insulin Biosimilars Market Outlook, By Disease Indication (2014-2023) ($MN)
47 Middle East & Africa Insulin Biosimilars Market Outlook, By Type I Diabetes (2014-2023) ($MN)
48 Middle East & Africa Insulin Biosimilars Market Outlook, By Type II Diabetes (2014-2023) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials